Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for August 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
FDA Could Green-Light COVID-19 Vaccines Before Clinical Trials Completed
MONDAY, Aug. 31, 2020 (HealthDay News) — Emergency use authorization (EUA) or approval for a COVID-19 vaccine before phase 3 clinical trials are complete could be considered by the U.S. Food and Drug Administration, according to the agency’s commissioner, Stephen Hahn, M.D.
AI Model Using Chest X-Ray May Predict 12-Year Lung Cancer Risk
MONDAY, Aug. 31, 2020 (HealthDay News) — A deep learning model based on chest radiograph (CXR) images and data from the electronic medical record (EMR) has better discrimination for smokers at high risk for incident lung cancer than Centers for Medicare & Medicaid Services (CMS) eligibility, according to a study published online Sept. 1 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Cannabis Use Increased Among Older Adults From 2016 to 2018
MONDAY, Aug. 31, 2020 (HealthDay News) — From 2016 to 2018, there was an increase in cannabis use among men and women aged 55 years and older, according to a research letter published online Sept. 1 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Community-Level Factors Explain Some Racial Disparities in COVID-19
MONDAY, Aug. 31, 2020 (HealthDay News) — Community-level factors explain some, but not all, racial and ethnic disparities in COVID-19 rates in Massachusetts, according to a report published online Aug. 27 in Health Affairs.
Use of Fitness Trackers May Spur Exercise in Older Adults With MS
MONDAY, Aug. 31, 2020 (HealthDay News) — Older adults with multiple sclerosis (MS) who say they use fitness trackers report greater amounts of physical activity, according to a study published online July 31 in the Disability & Health Journal.
Abstract/Full Text (subscription or payment may be required)
Long-Term Follow-Up Reported for BP Telemonitoring Program
MONDAY, Aug. 31, 2020 (HealthDay News) — Among adults with uncontrolled blood pressure, fewer cardiovascular events and lower costs were observed at five years with a pharmacist-led telemonitoring program, but the differences were not statistically significant compared with usual care, according to a study published online Aug. 31 in Hypertension.
Abstract/Full Text (subscription or payment may be required)
Use of Performance-Enhancing Substances Tied to Risk Behaviors
Napping Opportunity May Improve Clinical Performance of Anesthesia Residents
2021 to 2025 Saw Reduction in Burnout Indicators Among Pediatricians
Odds of Imaging Order Higher When Clinicians Self-Interpret
Considerable Global Disparities Found in Access to Dermatological Care
Distinct Skin Microbiome Features Emerge Before Atopic Disease Onset in Infants
Freshwater Swimming Tied to Stomach Bugs, Skin Conditions
Extreme Heat Linked to 33 Clinically Reportable Diagnoses
Psoriasis Linked to Impairment of Some Sleep Domains